How to Buy Precision Biosciences Stock
Precision Biosciences Inc
Precision BioSciences, Inc. , a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States.
Precision Biosciences stock last closed at $5.64, up 7.84% from the previous day, and has decreased 45.82% in one year. It has overperformed other stocks in the Biotechnology industry by 0.31 percentage points. Precision Biosciences stock is currently +56.23% from its 52-week low of $3.61, and -58.02% from its 52-week high of $13.44.
As of Apr 30, 2025, there are 10.48M shares of DTIL outstanding. The market cap of DTIL is $59.12M. In the past 24 hours, 137,974 DTIL shares were traded.
How to Buy Precision Biosciences Stock
Not sure how to invest in Precision Biosciences stock? Here's how.
- Decide where to buy Precision Biosciences stock: You need to pick a stock brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you figure out where to buy Precision Biosciences stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Fund your investment account: Select your payment method and add your details.
- Evaluate Precision Biosciences stock: The Precision Biosciences ticker symbol is DTIL. Is Precision Biosciences stock a good investment? Should you buy shares of DTIL? How do DTIL's underlying business fundamentals look? Do top analysts think Precision Biosciences is a good buy? Why has DTIL's stock price moved recently? (Hint: Our stock research website can help you understand if DTIL is a good stock to buy).
- Make your DTIL purchase: Decide if you will purchase DTIL shares at the current market price or use a limit order to purchase DTIL stock at a specific price.
- Track your DTIL position: Create a watchlist to key updates about your investment in Precision Biosciences shares.
Step 1: Decide where to buy Precision Biosciences stock
You will need an online brokerage account in order to access the NASDAQ market and buy DTIL stock.
Our favorite brokerage: eToro
In our opinion, eToro is the best brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world markets: From Technology to Utilities, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've selected your brokerage, you need to fill out some personal info so you can buy DTIL today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to create a new trading account.
- Send your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you've opened your account on a mobile trading app, your next step is to transfer the money for your investment:
Check out the video below if you need help depositing money into your investment account.
Step 4: Evaluate Precision Biosciences stock
After you have selected the best place to buy Precision Biosciences stock, it's important to research their stock prior to buying, so you truly wrap your head around the risk and upside.
Overview of key DTIL info
Fundamentals of Precision Biosciences
WallStreetZen was created to help average investors perform more accurate fundamental analysis quickly.
You can see all of the due diligence checks on DTIL's stock page.
Is DTIL stock undervalued or overvalued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge DTIL's fair value.
Using relative valuations measures:
- DTIL may be undervalued based on its P/E ratio of 5.37x, relative to Biotechnology industry P/E ratio of -162.28x
- DTIL could be undervalued based on its P/B ratio of 1.05x, relative to Biotechnology industry P/B ratio of 4.45x
You can do more valuation research on DTIL's stock here.
DTIL Financial Health Overview
Positive Financial Indicators:
- DTIL profit margin has gone up from -125.8% to 10.4% in the past year.
- DTIL has cash burn of 58635000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the DTIL balance sheet.
- There are more short-term assets than short-term liabilities on the DTIL balance sheet.
Negative Financial Indicators:
- DTIL has a relatively high debt to equity ratio of 1.42.
- DTIL has $108.88M in cash and short term investments. This is not enough to cover its annual cash burn of $58.64M.
- Total DTIL debt is higher than 5 years ago, relative to shareholder equity.
Is it a good time to buy DTIL stock, according to analysts?
Out of 2 Wall Street analysts who research DTIL, the consensus analyst rating on DTIL is a Buy
Please note that analyst ratings are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are projecting on the Precision Biosciences stock forecast page.
Metrics for Advanced DTIL Traders
DTIL Performance Metrics
Last year, DTIL revenue was $68.70M. Over the past 5 year, DTIL's revenue has gone up by 25.3% per year. This was slower than the Biotechnology industry average of 45.66%.
Learn more about DTIL's earnings and revenue performance here.
Are DTIL insiders buying or selling the stock?
Over the past year, executives and large shareholders at DTIL have sold more shares than they have bought.
Melinda Brown, Director of DTIL, was the latest DTIL insider to buy. They bought $8,735.25 worth of DTIL shares on Mar 26, 2025.
Research more about who owns DTIL shares here.
Can I get consistent income from DTIL stock?
No, Precision Biosciences doesn't provide an income stream by paying out dividends.
DTIL Social Trading Data
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Make your DTIL purchase
You have two main order types:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are generally the best for newer investors. - Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a specific price, use a limit order.
Hit the Open Trade button and your broker will place the order.
If you need more info about buying stocks on eToro, watch the how to video below:
Step 6: Track your DTIL position
Now that you own some DTIL shares, you'll want to stay up-to-date on your new stock purchase.
Start a watchlist to track your DTIL stock.
DTIL Feed
How to Buy Stock in Precision Biosciences
To summarize, here are the 6 steps you need to take to buy Precision Biosciences stock right now:
- Decide where to buy Precision Biosciences stock
- Sign up for your brokerage account
- Fund your investment account
- Evaluate Precision Biosciences stock
- Make your DTIL purchase
- Track your DTIL position
If you require a brokerage account, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to get the latest news on your new investment in Precision Biosciences, get started below.
Trending Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.